First-line treatment and overall survival in EGFR mutation-positive advanced non-small cell lung cancer: a national cohort study. - Huang LY; Chang HP; Chang RY; Tai HY; Huang YW; Lee PC (European review for medical and pharmacological sciences, 2022)